As in the past, ASCA has partnered with Voices for Non-Opioid Choices (Voices) to support the introduction of the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act (S. 586/H.R. 3259) in Congress. As of June 2022, the legislation has more than 150 cosponsors, with more than 100 in the House and more than 50 in the Senate. The bill has seen significant traction and the provisions it contains could pass individually or be adopted in a larger legislative mechanism before the end of this Congress.